Clinical commissioning policy: prescribing of gender affirming hormones (masculinising or feminising hormones) as part of the children and young people’s gender service

Document first published:
Page updated:
Topic:
,
Publication type:

NHS England will commission this intervention as part of the specialised service for Children and Young People with Gender Incongruence. In creating this policy NHS England has reviewed this clinical condition and the options for its treatment. It has considered the place of this treatment in current clinical practice, whether scientific research has shown the treatment to be of benefit to patients, (including how any benefit is balanced against possible risks) and whether its use represents the best use of NHS resources. This policy document outlines the arrangements for funding of this treatment for the population in England.

Document

Clinical commissioning policy: prescribing of gender affirming hormones (masculinising or feminising hormones) as part of the children and young people’s gender service

Clinical commissioning policy: prescribing of gender affirming hormones (masculinising or feminising hormones) as part of the children and young people’s gender service

  • PDF
  • 145 KB
  • 8 pages